FRI057 Drug Concentrations And Dosing Considerations For Mibavademab, A Novel Leptin Receptor Agonist, In Individuals With Generalized Lipodystrophy
FRI057 药物浓度和剂量考虑因素：Mibavademab（一种新型瘦素受体激动剂）在全身性脂肪营养不良患者中的应用
期刊:Journal of Environmental Quality
影响因子:2.3
doi:10.2134/jeq2013.01.0012
Popova, Inna E; Bair, Daniel A; Tate, Kenneth W; Parikh, Sanjai J; Foss de Freitas, Maria Cristina; DillGomes, Anabela; Neidert, Adam; Podgrabinska, Simona; Olenchock, Ben; SinhaRoy, Rababir; Harris, Charles Andrew; Akinci, Baris; Altarejos, Judith; Oral, Elif A; Tebas, Pablo; Agnes, Joseph; Giffear, Mary; Kraynyak, Kimberly A; Blackwood, Elliott; Amante, Dinah; Reuschel, Emma; Liu, Neiman; Purwar, Mansi; Christensen-Quick, Aaron; Andrade, Viviane M; Carter, Julie; Garufi, Gabriella; Diehl, Malissa; Sylvester, Albert; Morrow, Matthew P; Pezzoli, Patrick P; Kulkarni, Abhijeet J; Zaidi, Faraz I; Frase, Drew; Liaw, Kevin; Patel, Ami; Buttigieg, Karen R; Ervin, John E; Pawlicki, Jan; Gillespie, Elisabeth; Maricic, Igor; Schultheis, Katherine; Badie, Hedieh; Herring, Timothy A; Simon, Keiko O; Smith, Trevor R F; Ramos, Stephanie; Spitz, Robert; Lee, Jessica; Dallas, Michael; Brown, Ami Shah; Shea, Jacqueline E; Kim, J Joseph; Weiner, David; Broderick, Kate; McMullan, Trevor; Boyer, Jean; Humeau, Laurent; Mammen Jr., Mammen P; Mendell, Jeanne; Wang, Yuhuan; Olenchock, Ben A; Podgrabinska, Simona; Pagovich, Odelya E; Oral, Elif A; Brown, Rebecca J; Davis, John
